전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Gahlemann, M."]
총 50건 
※ 페이지 이동 시, 중복 레코드가 제거되므로 초기 검색결과 수와 차이가 있을 수 있습니다.
5/5 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (52)
    • Magazines (5)

    재검색

  • 주제
    • lung diseases, interstitial (12)
    • scleroderma, systemic (11)
    • indoles (9)

    더보기

    재검색

  • 간행물
    • american journal of respiratory and critical care medicine (8)
    • annals of the rheumatic diseases (8)
    • revue des maladies respiratoires actualites (6)

    더보기

    재검색

  • 출판사
    • amer thoracic soc (8)
    • bmj publishing group (6)
    • elsevier masson sas (4)

    더보기

    재검색

  • 언어
    • english (48)
    • french (4)

    재검색

  • Publication Year
    • 2019 (1)
    • 2020 (1)

    재검색

  • 수록데이터베이스
    • Science Citation Index Expanded (21)
    • MEDLINE (19)
    • ScienceDirect (9)

    더보기

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

41
Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial. 미리보기

학술저널

issue
Respiratory investigation [Respir Investig] 2021 Mar; Vol. 59 (2), pp. 252-259. Date of Electronic Publication: 2020 Nov 19.
Author
Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan. Electronic address: azuma_arata@yahoo.co.jp.
Chung L; Departments of Medicine and Dermatology, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.
Behera D; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Chung M; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.
Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Centre, Yokohama, Japan.
Okamoto M; Department of Internal Medicine, Division of Respirology, Neurology, and Rheumatology, Kurume University School of Medicine, Japan.
Swarnakar R; Department of Respiratory Medicine, Getwell Hospital and Research Institute, Nagpur, Maharashtra, India.
Zeng X; Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China.
Zou H; Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
Meng X; Boehringer Ingelheim (China) Investment Co., Ltd, Shanghai, China.
Gahlemann M; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland.
Alves M; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  조회 - Impact Factor (JCR) 
42
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. 미리보기

학술저널

issue
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jan; Vol. 9 (1), pp. 96-106.
Author
Highland KB; Cleveland Clinic, Cleveland, OH, USA.
Distler O; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
Allanore Y; Department of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France.
Assassi S; Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, USA.
Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Bourdin A; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France.
Denton CP; University College London Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, London, UK.
Distler JHW; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany.
Hoffmann-Vold AM; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
Khanna D; Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
Mayes MD; Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, USA.
Raghu G; Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA.
Vonk MC; Department of Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands.
Gahlemann M; Boehringer Ingelheim (Schweiz), Basel, Switzerland.
Clerisme-Beaty E; Boehringer Ingelheim International, Ingelheim am Rhein, Germany.
Girard M; Boehringer Ingelheim Pharma, Biberach, Germany.
Stowasser S; Boehringer Ingelheim International, Ingelheim am Rhein, Germany.
Zoz D; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.
Maher TM; National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: toby.maher@med.usc.edu.
DB Label
Database : MEDLINE
원문보기
Full Text (Clinical Key)  등재 - Web of Science (SCIE)  조회 - Impact Factor (JCR) 
44
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations. 미리보기

학술저널

issue
BMJ open [BMJ Open] 2020 Dec 16; Vol. 10 (12), pp. e039473. Date of Electronic Publication: 2020 Dec 16.
Author
Roennow A; Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium.; Sklerodermiforening, Rødovre, Denmark.
Sauvé M; Scleroderma Canada, Hamilton, Ontario, Canada.
Welling J; Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium joep.at.fesca@gmail.com.
Riggs RJ; Scleroderma Foundation, Inc, Danvers, Massachusetts, USA.
Kennedy AT; Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium.
Galetti I; Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium.; Gruppo Italiano per la Lotta alla Sclerodermia, Milan, Italy.
Brown E; Scleroderma and Raynaud's UK, London, UK.
Leite C; Portuguese Association of Patients with Scleroderma, Monção, Portugal.
Gonzalez A; Scleroderma Research Foundation, San Francisco, California, USA.
Portales Guiraud AP; Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium.; Asociación Española de Esclerodermia, Madrid, Spain.
Houÿez F; EURORDIS-Rare Diseases Europe, Barcelona, Spain.
Camp R; EURORDIS-Rare Diseases Europe, Barcelona, Spain.
Gilbert A; AK Gilbert Ltd, Brighton, UK.
Gahlemann M; Boehringer Ingelheim Schweiz GmbH, Basel, BS, Switzerland.
Moros L; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany.
Luna Flores JL; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany.
Schmidt F; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany.
Sauter W; Boehringer Ingelheim Pharma GmbH and Co KG Biberach, Biberach, Baden-Württemberg, Germany.
Finnern H; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
45
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial. 미리보기

학술저널

issue
Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Nov; Vol. 79 (11), pp. 1478-1484. Date of Electronic Publication: 2020 Aug 05.
Author
Seibold JR; Scleroderma Research Consultants, LLC, Aiken, South Carolina, USA jamesrseibold@gmail.com.
Maher TM; National Heart and Lung Institute, Imperial College London, London, UK.; National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Highland KB; Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Assassi S; University of Texas Houston Medical School, Houston, Texas, USA.
Azuma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Hummers LK; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Costabel U; Interstitial and Rare Lung Disease Unit, Department of Pneumology, Ruhrlandklinik, University Hospital Essen, Essen, Germany.
von Wangenheim U; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Kohlbrenner V; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
Gahlemann M; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland.
Alves M; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Distler O; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
DB Label
Database : MEDLINE
원문보기
Full Text (BMJ Journals)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
48
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study. 미리보기

학술저널

issue
Respiratory research [Respir Res] 2015 Aug 18; Vol. 16, pp. 97. Date of Electronic Publication: 2015 Aug 18.
Author
O'Byrne PM; Firestone Institute for Respiratory Health, and Department of Medicine, McMaster University Medical Centre, 1280 Main Street West, Room 3 W10, Hamilton, ON, L8S 4 K1, Canada. obyrnep@mcmaster.ca.
D'Urzo T; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. tonydurzo@sympatico.ca.
Beck E; Institut für Gesundheitsförderung GmbH, Rüdersdorf, Germany. beck@ifg-forschung.de.
Fležar M; Hospital Golnik, Clinical Department of Pulmonology and Allergy, Golnik, Slovenia. matjaz.flezar@klinika-golnik.si.
Gahlemann M; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland. martina.gahlemann@boehringer-ingelheim.com.
Hart L; Boehringer Ingelheim Canada Ltd, Burlington, ON, Canada. lorna.hart@boehringer-ingelheim.com.
Blahova Z; Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria. zuzana.blahova@boehringer-ingelheim.com.
Toorawa R; Boehringer Ingelheim Ltd, Bracknell, UK. robert.toorawa.ext@boehringer-ingelheim.com.
Beeh KM; insaf Respiratory Research Institute, Wiesbaden, Germany. k.beeh@insaf-wi.de.
DB Label
Database : MEDLINE
원문보기
OA (Springer)  Open Access (PubMed Central)  Open Access (BioMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
1 2 3 4 5 
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 149490
  • 127373989